No Data
No Data
H.C. Wainwright Initiates Editas Medicine(EDIT.US) With Buy Rating, Announces Target Price $3
Express News | Editas Medicine Announces Five Abstracts At 28th Annual Meeting Of American Society Of Gene And Cell Therapy
Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in Vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
Editas Medicine Analyst Ratings
HC Wainwright Initiates Coverage on Editas Medicine With Buy Rating, $3 Price Target
Express News | Editas Medicine, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $3